首页> 外文OA文献 >Cosmetics Europe compilation of historical serious eye damage/eye irritation in vivo data analysed by drivers of classification to support the selection of chemicals for development and evaluation of alternative methods/strategies: the Draize eye test Reference Database (DRD)
【2h】

Cosmetics Europe compilation of historical serious eye damage/eye irritation in vivo data analysed by drivers of classification to support the selection of chemicals for development and evaluation of alternative methods/strategies: the Draize eye test Reference Database (DRD)

机译:欧洲化妆品市场对历史上严重的眼部损伤/眼睛刺激性体内数据的汇编,由分类驱动器进行了分析,以支持化学药品的选择,以开发和评估其他方法/策略:Draize眼部测试参考数据库(DRD)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A thorough understanding of which of the effects assessed in the in vivo Draize eye test are responsible for driving UN GHS/EU CLP classification is critical for an adequate selection of chemicals to be used in the development and/or evaluation of alternative methods/strategies and for properly assessing their predictive capacity and limitations. For this reason, Cosmetics Europe has compiled a database of Draize data (Draize eye test Reference Database, DRD) from external lists that were created to support past validation activities. This database contains 681 independent in vivo studies on 634 individual chemicals representing a wide range of chemical classes. A description of all the ocular effects observed in vivo, i.e. degree of severity and persistence of corneal opacity (CO), iritis, and/or conjunctiva effects, was added for each individual study in the database and the studies were categorised according to their UN GHS/EU CLP classification and the main effect driving the classification. An evaluation of the various in vivo drivers of classification compiled in the database was performed to establish which of these are most important from a regulatory point of view. These analyses established that the most important drivers for Cat 1 Classification are (i) CO mean ≥ 3 (days 1-3) (severity) and (ii) CO persistence on day 21 in the absence of severity and those for Cat 2 classification are (iii) CO mean ≥ 1 and (iv) conjunctival redness mean ≥ 2. Moreover, it is shown that all classifiable effects (including persistence and CO = 4) should be present in >60% of the animals to drive a classification. As a consequence, our analyses suggest the need for a critical revision of the UN GHS/EU CLP decision criteria for the Cat 1 classification of chemicals. Finally, a number of key criteria are identified that should be taken into consideration when selecting reference chemicals for the development, evaluation and/or validation of alternative methods and/or strategies for serious eye damage/eye irritation testing. Most important, the DRD is an invaluable tool for any future activity involving the selection of reference chemicals.
机译:彻底了解在体内Draize眼试验中评估出的哪些效应可推动联合国GHS / EU CLP分类,这对于在开发和/或评估替代方法/策略以及正确评估其预测能力和局限性。因此,欧洲化妆品公司从外部清单中收集了Draize数据的数据库(Draize眼试验参考数据库,DRD),该清单是为支持过去的验证活动而创建的。该数据库包含681种独立的体内研究,涉及634种代表广泛化学类别的化学物质。在数据库中为每个单独的研究增加了对体内观察到的所有眼部影响的描述,即严重程度和角膜混浊(CO)的持续性,虹膜炎和/或结膜作用,并根据研究的联合国对其进行了分类GHS / EU CLP分类以及驱动分类的主要作用。对数据库中汇编的各种体内分类驱动因素进行了评估,以从监管角度确定其中哪些最重要。这些分析确定,Cat 1分类最重要的驱动因素是(i)CO均值≥3(1-3天)(严重性)和(ii)在没有严重程度的情况下第21天的CO持久性,而Cat 2分类的原因是(iii)CO均值≥1,并且(iv)结膜发红度均值≥2。此外,已证明应在> 60%的动物中出现所有可分类的影响(包括持久性和CO = 4),以进行分类。因此,我们的分析表明,需要对Cat 1类化学品的联合国GHS / EU CLP决策标准进行重大修订。最后,在选择参考化学品以开发,评估和/或验证严重眼损伤/眼刺激性测试的替代方法和/或策略时,应确定许多关键标准。最重要的是,DRD是涉及参考化学品选择的任何未来活动的宝贵工具。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号